Predictive and prognostic markers for epidermal growth factor receptor inhibitor therapy in non-small cell lung cancer

N Peled, K Yoshida, MW Wynes… - … advances in medical …, 2009 - journals.sagepub.com
Review: Predictive and prognostic markers for epidermal growth factor receptor inhibitor
therapy in non-small cell lung cancer Page 1 Predictive and prognostic markers for epidermal …

Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities

H Modjtahedi, S Essapen - Anti-cancer drugs, 2009 - journals.lww.com
… , each EGFR TKI inhibitor may have a unique set of predictive markers. The challenge is …
predictive markers for each EGFR inhibitor. Recent studies also suggest that a predictive marker

Biomarkers predicting clinical outcome of epidermal growth factor receptor–targeted therapy in metastatic colorectal cancer

S Siena, A Sartore-Bianchi… - Journal of the …, 2009 - academic.oup.com
… emerged as an important predictive marker of resistance to … The epidermal growth factor
receptor (EGFR), a member of … is not predictive of response to EGFR inhibitors. It is now clear …

Predictive molecular markers of response to epidermal growth factor receptor (EGFR) family-targeted therapies

S Barton, N Starling, C Swanton - Current cancer drug targets, 2010 - ingentaconnect.com
… This review will discuss potential predictive molecular markers of response and resistance
to EGFRtargeted therapies in mCRC, NSCLC and breast cancer. We will focus on the …

The biology of epidermal growth factor receptor and its value as a prognostic/predictive factor

APD Tos - The International journal of biological markers, 2007 - journals.sagepub.com
… Epidermal growth factor receptor inhibitors in colorectal cancer: It’s time to get back on target…
Analysis of epidermal growth factor receptor expression as a predictive factor for response …

Baseline vascular endothelial growth factor concentration as a potential predictive marker of benefit from vandetanib in non–small cell lung cancer

EO Hanrahan, AJ Ryan, H Mann, SJ Kennedy… - Clinical Cancer …, 2009 - AACR
growth factor (VEGF) levels from three randomized, phase II clinical studies of vandetanib
(oral VEGF/epidermal growth factor receptor inhibitor… epidermal growth factor receptor inhibitor

Epidermal growth factor receptor inhibitor–related skin toxicity: mechanisms, treatment, and its potential role as a predictive marker

D Bianchini, A Jayanth, YJ Chua… - Clinical colorectal cancer, 2008 - Elsevier
The human epidermal growth factor receptor (HER1/EGFR/ErbB1) signaling is aberrant and
overexpressed in many solid malignancies making it an appealing target for biologic agents…

… growth factor receptor 2 in non-muscle invasive bladder cancer: issues in assessment methods and its role as prognostic/predictive marker and putative therapeutic …

F Sanguedolce, D Russo, V Mancini… - Urologia …, 2019 - karger.com
… 121 Hegazy R, Hegazy A, Kamel M, El-Farargy O, Nawar N, El-Atar A: Role of human epidermal
growth factor receptor 2 antagonist (Trastuzumab) in the management of nonmuscle-…

Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa®, ZD1839) in chemotherapy‐resistant non‐small …

SW Han, PG Hwang, DH Chung… - … journal of cancer, 2005 - Wiley Online Library
… In investigations to identify predictive markers of response to … patients after treatment with
EGFR inhibitors,17 and reduced … attempt to identify predictive markers of response to gefitinib. …

Epidermal growth factor receptor tyrosine kinase inhibitors

M Ranson - British journal of cancer, 2004 - nature.com
… trial design, they have not resulted in the identification of a validated, predictive marker for
antitumour efficacy. Molecular imaging of pharmacodynamic effects and visualisation of target …